Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Reduction of BK Viremia in Kidney Transplant Patients

NCT: NCT04984902 · WITHDRAWN

NCT IDNCT04984902
StatusWITHDRAWN
Start Date2022-02-01
Completion2023-04-01

Brief Summary

Reduction of BK Viremia by treating kidney transplant patients.

Frequently Asked Questions

What is Reduction of BK Viremia in Kidney Transplant Patients?

Reduction of BK Viremia in Kidney Transplant Patients is a clinical trial registered under NCT04984902. Current status: WITHDRAWN.

What is the status of NCT04984902?

The current status of NCT04984902 (Reduction of BK Viremia in Kidney Transplant Patients) is: WITHDRAWN.

When did Reduction of BK Viremia in Kidney Transplant Patients start?

Reduction of BK Viremia in Kidney Transplant Patients started on 2022-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑